This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 08 Oct 2021  |  North America

    Global Tissue Diagnostics (TDx) Growth Opportunities

    Companion Diagnostics (CDx)-specific Advanced Staining and Anatomical Pathology Laboratory Information Systems (APLIS) to Drive Ma

    This research service provides an overview of the global TDx market and a 4-year forecast of it from 2021 to 2025. The market will reach $8,848.6 million in 2025, growing at a compound annual growth rate (CAGR) of 8.9% from 2020 to 2025. The advanced staining and anatomical pathology laboratory information management systems (APLIS) segments will g...

    $4,950.00
  2. 06 Oct 2021  |  North America

    US Chronic Disease Management Growth Opportunities

    Future Growth Potential Enhanced by the Pandemic and Growth Opportunities in Chronic Disease Management

    The prevalence of chronic diseases has continued to rise, and the expenses of managing them or treating the complications arising from poor management cost the US healthcare system hundreds of billions of dollars each year. Clearly, physicians alone cannot control this rising challenge, and to ensure behavioral change, several tools and approaches ...

    $4,950.00
  3. 28 Sep 2021  |  Global

    Global Healthcare Cloud Growth Opportunities

    Competitive Intensity Drives the Growth Potential of Hybrid and Multi-cloud Deployment Models

    The COVID-19 pandemic has shown that many healthcare organizations do not have the necessary agility and business continuity programs or technologies to support them during crises. It is forcing businesses to act on cloud and digital transformation strategies that they had been delaying until now. The cloud is more critical than ever in helping...

    $4,950.00
  4. 28 Sep 2021  |  Global

    Global Automated Endoscope Reprocessors (AER) Growth Opportunities

    Breakthrough Technologies and Strategic Collaborations Drive Growth Strategies

    While the entire healthcare industry adapts to changes induced by the COVID-19 pandemic, the endoscope reprocessing industry undergoes a major technology transformation. The rise in multiple infection outbreaks from contaminated endoscopes due to faulty endoscope reprocessing and manual errors in cleaning presents huge growth potential for automate...

    $4,950.00
  5. 28 Sep 2021  |  Global

    Global Automated Endoscope Reprocessors (AER) Growth Opportunities

    Breakthrough Technologies and Strategic Collaborations Drive Growth Strategies

    While the entire healthcare industry adapts to changes induced by the COVID-19 pandemic, the endoscope reprocessing industry undergoes a major technology transformation. The rise in multiple infection outbreaks from contaminated endoscopes due to faulty endoscope reprocessing and manual errors in cleaning presents huge growth potential for automate...

    $4,950.00
  6. 28 Sep 2021  |  Global

    Global Healthcare Cloud Growth Opportunities

    Competitive Intensity Drives the Growth Potential of Hybrid and Multi-cloud Deployment Models

    The COVID-19 pandemic has shown that many healthcare organizations do not have the necessary agility and business continuity programs or technologies to support them during crises. It is forcing businesses to act on cloud and digital transformation strategies that they had been delaying until now. The cloud is more critical than ever in helping...

    $4,950.00
  7. 20 Sep 2021  |  North America

    Global In Vitro Diagnostics Market Outlook, 2021

    Personalized Diagnostics and Increased Healthcare Investment to Drive Market Growth Post COVID-19 Pandemic

    The change in reimbursement for diagnostic testing, pressure from PAMA, regulatory trends in Europe, demand for large-scale testing, shift to precision diagnostics, emerging companies, and evolving business models demand assessing portfolio, evaluating competitor strategies, and exploring opportunities for business growth. The competitive nature of...

    $4,950.00
  8. 13 Sep 2021  |  North America

    Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities

    Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential

    This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of...

    $4,950.00
  9. 09 Sep 2021  |  North America

    Global Medical Device Leasing Growth Opportunities

    Vendors' Integration of Support Services and Shift from Product-centric to Value-oriented Business Models will Improve ROI and Mar

    Globally, hospitals and health systems face financial pressure caused by high operating and administrative costs, declining revenue and reimbursement rates, and the increasing cost of both medical devices (due to technology advancements) and infrastructure. The COVID-19 pandemic has intensified this financial crisis as patient volumes dropped and n...

    $2,450.00
  10. 03 Sep 2021  |  North America

    Global Renal Care Management Growth Opportunities

    Value-based Renal Care to be a Key Growth Area

    The global prevalence of CKD is estimated to be about 9% to 10%. Chronic Kidney Disease (CKD) is associated with poor outcomes, mainly due to the high burden of comorbidity. Along with rising aging population, increasing number of CKD patients are suffering from comorbidities such as hypertension, diabetes, heart failure, cancer, and mental ill hea...

    $4,950.00